amlodipine has been researched along with mibefradil in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 24 (54.55) | 18.2507 |
2000's | 18 (40.91) | 29.6817 |
2010's | 2 (4.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Cho, YS; Hwang, EM; Jung, SY; Lim, SM; Min, SJ; Pae, AN; Park, KD; Viswanath, AN | 1 |
Clozel, JP; Hess, P; Véniant, M; Wolfgang, R | 1 |
Bühler, FR; Clozel, JP; Iberg, N; Schmitt, R | 1 |
Bühler, M; Clozel, JP; Roux, S | 1 |
Bernink, PJ; Kantola, IM; Kobrin, I; Ribeiro, AB; Schelling, A; Viskoper, RJ; Wilkins, MR | 1 |
Kobrin, I; Lacourcière, Y; Massie, BM; Viskoper, R; Woittiez, A | 1 |
Davies, GJ; Kobrin, I; Tzivoni, D | 1 |
Charlon, V; Kobrin, I; Lindberg, E; Pordy, R | 1 |
Braat, S; Kadr, H; Kobrin, I; Ramires, JA; Rutsch, W; Tzivoni, D | 1 |
Koen, R; Lacolley, P; Levy, BI; Poitevin, P | 1 |
Bieska, G; Charlon, V; Kobrin, I; Lindberg, E; Pordy, R | 1 |
Alhenc Gelas, F; Huang, W; Osborne-Pellegrin, MJ | 1 |
Massie, BM | 1 |
Hinder, M; Kieninger, M; Krämer, BK; Kurtz, A; Wagner, C | 1 |
Greven, J | 1 |
Kam, KL; Pfaffendorf, M; van der Lee, R; van Zwieten, PA | 1 |
Backenköhler, U; Dörge, H; Heusch, G; Jalowy, A; Post, H; Schulz, R; Vahlhaus, C | 1 |
Cleophas, TJ; Daniëls, MC; Hendriks, MG; Holwerda, NJ; Schelling, A; Van Der Vring, JA; Withagen, PJ | 2 |
Chen, H; Daloze, P; Dumont, L; Lapointe, N; Qi, S; Xu, D | 1 |
Cleophas, TJ; Daniëls, MC; Hendriks, MG; Holwerda, KJ; Schelling, A; van der Sluijs, J; van der Vring, JA; Withagen, AJ; Zwinderman, AH | 1 |
Frohlich, ED; Nakamura, Y; Ono, H | 1 |
Hinder, M; Krämer, BK; Kurtz, A; Wagner, C | 1 |
Bruneval, P; Clozel, JP; Gonzalez, MF; Karam, H; Ménard, J | 1 |
Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T | 1 |
Göthert, M; Likungu, J; Molderings, GJ | 1 |
Antepohl, W; Haaf, O; Herzig, S; Huber, I; Matthes, J; Striessnig, J | 1 |
Bénardeau, A; Ertel, EA; Perchenet, L | 1 |
Avdonin, PV; Buhler, FR; Tkachuk, VA | 1 |
Claas, R; Cleutjens, JP; Daemen, MJ; Sandmann, S; Unger, T | 1 |
Darné, B; Démolis, JL; Funck-Brentano, C; Jaillon, P; Ragueneau, I; Sao, AB | 1 |
Doğrul, A; Güzeldemir, EM; Işmer, A; Yeşilyurt, Ö | 1 |
Baylis, C; Engels, K; Qiu, C | 1 |
Lijnen, PJ | 1 |
Holzhausen, C; Nebe, B; Rychly, J; Urbaszek, W | 1 |
Champagne, S; Crozatier, B; Ennezat, PV; Heloire, F; Hittinger, L; Houel, R; Sambin, L; Su, JB; Suto, Y | 1 |
Buranakitcharoen, P; Sermswan, A; Sukontasarn, A; Suthichaiyakul, T; Uboldejpracharak, Y | 1 |
Abu-Amarah, I; Bidani, AK; Griffin, KA; Hacioglu, R; Loutzenhiser, R; Williamson, GA | 1 |
Allen, TJ; Cao, Z; Cooper, ME; Ma, G | 1 |
Ekholm, M; Hjemdahl, P; Kahan, T; Lindqvist, M; Melcher, A | 1 |
2 review(s) available for amlodipine and mibefradil
Article | Year |
---|---|
Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
Topics: Adolescent; Adult; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Safety; Tetrahydronaphthalenes | 1998 |
Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris.
Topics: Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Diltiazem; Humans; Mibefradil; Tetrahydronaphthalenes | 1998 |
11 trial(s) available for amlodipine and mibefradil
Article | Year |
---|---|
A randomised, double-blind trial comparing mibefradil and amlodipine: two long-acting calcium antagonists with similar efficacy but different tolerability profiles. Mibefradil International Study Group.
Topics: Adult; Aged; Amlodipine; Benzimidazoles; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Hypertension; Male; Mibefradil; Middle Aged; Tetrahydronaphthalenes | 1997 |
Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
Topics: Adult; Aged; Amlodipine; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Edema; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Leg; Male; Mibefradil; Middle Aged; Nifedipine; Tetrahydronaphthalenes | 1997 |
Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Diltiazem; Female; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Nitroglycerin; Tetrahydronaphthalenes | 1997 |
Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist.
Topics: Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Drug Administration Schedule; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Hypertension; Male; Mibefradil; Middle Aged; Nifedipine; Tetrahydronaphthalenes | 1997 |
Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Double-Blind Method; Electrocardiography, Ambulatory; Exercise; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Nitroglycerin; Prospective Studies; Tetrahydronaphthalenes; Vasodilator Agents | 1997 |
Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
Topics: Adolescent; Adult; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Safety; Tetrahydronaphthalenes | 1998 |
Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascul
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dizziness; Double-Blind Method; Drug Therapy, Combination; Exercise; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Risk Assessment; Tetrahydronaphthalenes | 1999 |
Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Resear
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dizziness; Double-Blind Method; Drug Combinations; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Physical Exertion; Tetrahydronaphthalenes; Time Factors | 1999 |
Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: beneficial effect of calcium channel blockers largely determined by their effect on heart rate.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Death, Sudden; Diltiazem; Dizziness; Double-Blind Method; Drug Therapy, Combination; Exercise; Exercise Test; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Regression Analysis; Tetrahydronaphthalenes; Treatment Outcome | 1999 |
Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers.
Topics: Administration, Oral; Adult; Aldosterone; Amlodipine; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Electrocardiography; Epinephrine; Hemodynamics; Humans; Male; Mibefradil; Nifedipine; Sympathetic Nervous System | 2001 |
Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cross-Over Studies; Double-Blind Method; Female; Heart; Heart Rate; Humans; Hypertension; Male; Mibefradil; Middle Aged; Norepinephrine; Sympathetic Nervous System; Time Factors; Ultrasonography | 2007 |
32 other study(ies) available for amlodipine and mibefradil
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Identification of the first in silico-designed TREK1 antagonists that block channel currents dose dependently.
Topics: Animals; Computer Simulation; Crystallography, X-Ray; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Mice; Mice, Knockout; Molecular Docking Simulation; Potassium Channels, Tandem Pore Domain | 2016 |
Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Hemodynamics; Male; Mibefradil; Nifedipine; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Verapamil | 1991 |
Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Carotid Artery Injuries; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Membrane Potentials; Mibefradil; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Tetrahydronaphthalenes; Tunica Intima; Verapamil | 1995 |
Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
Topics: Amlodipine; Angina Pectoris, Variant; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Dogs; Heart Rate; Intra-Aortic Balloon Pumping; Mibefradil; Myocardial Ischemia; Tetrahydronaphthalenes | 1996 |
Different effects of calcium antagonists on fluid filtration of large arteries and albumin permeability in spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Capillary Permeability; Carotid Arteries; Edema; Heart Rate; Hemodynamics; Hypertension; Male; Mibefradil; Nifedipine; Rats; Rats, Inbred SHR; Serum Albumin; Tetrahydronaphthalenes | 1998 |
Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Rupture; Benzimidazoles; Blood Pressure; Body Weight; Calcium Channel Blockers; Collagen; Elastic Tissue; Elastin; Enalapril; Heart; Heart Rate; Losartan; Male; Mibefradil; Muscle, Smooth, Vascular; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred BN; Renin; Renin-Angiotensin System; Tetrahydronaphthalenes | 1998 |
T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
Topics: Amlodipine; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Cells, Cultured; Enzyme Precursors; Gene Expression Regulation, Enzymologic; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Rate; Juxtaglomerular Apparatus; Male; Mibefradil; Mice; Rats; Rats, Sprague-Dawley; Renal Artery; Renin; Ribonucleases; RNA, Messenger; Tetrahydronaphthalenes | 1998 |
Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
Topics: Amlodipine; Anesthesia; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Glomerular Filtration Rate; Kidney; Kidney Function Tests; Male; Mibefradil; Potassium; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium; Tetrahydronaphthalenes; Urodynamics | 1998 |
Differential time course of the vasodilator action of various calcium antagonists.
Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; In Vitro Techniques; Male; Mesenteric Arteries; Mibefradil; Rats; Rats, Wistar; Tetrahydronaphthalenes; Time Factors; Vasodilation; Vasodilator Agents | 1998 |
Unique cardioprotective action of the new calcium antagonist mibefradil.
Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Glyburide; Heart; Heart Rate; Heart Ventricles; Mibefradil; Myocardial Infarction; Pressure; Swine; Tetrahydronaphthalenes; Verapamil | 1999 |
Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
Topics: Adjuvants, Immunologic; Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Therapy, Combination; Felodipine; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mibefradil; Rats; Rats, Inbred Lew; Tetrahydronaphthalenes; Time Factors | 1999 |
Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Calcium Channel Blockers; Calcium Channels; Creatinine; Data Interpretation, Statistical; Enzyme Inhibitors; Glomerular Filtration Rate; Heart; Hemodynamics; Hypertension; Kidney; Kidney Glomerulus; Kidney Tubules; Male; Mibefradil; Nephrocalcinosis; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Inbred SHR; Tetrahydronaphthalenes; Uric Acid; Vasodilator Agents | 1999 |
Role of sympathetic nerves in the differential effects of T-type and L-type calcium channel blockers on renin secretion and renin gene expression.
Topics: Amlodipine; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Male; Mibefradil; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Sympathetic Nervous System; Tetrahydronaphthalenes | 1999 |
Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.
Topics: Amlodipine; Analysis of Variance; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Calcium Channels; Coronary Circulation; Desoxycorticosterone; Hemodynamics; Hypertension; Kidney Glomerulus; Male; Mibefradil; Organ Size; Rats; Rats, Wistar; Renin | 1999 |
Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Topics: Adrenergic beta-Agonists; Aequorin; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Heart; Heart Function Tests; Hemodynamics; Isometric Contraction; Isoproterenol; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardium; Papillary Muscles; Rats; Rats, Wistar; Verapamil | 1999 |
N-Type calcium channels control sympathetic neurotransmission in human heart atrium.
Topics: Adult; Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, N-Type; Diltiazem; Electric Stimulation; Female; Heart; Heart Atria; Humans; Male; Mibefradil; Middle Aged; Norepinephrine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Sympathetic Nervous System; Synaptic Transmission; Verapamil | 2000 |
Pharmacodynamic interaction between mibefradil and other calcium channel blockers.
Topics: Amlodipine; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Cell Membrane; Dihydropyridines; Drug Interactions; Ethosuximide; Female; Gallopamil; Humans; In Vitro Techniques; Isradipine; Male; Mibefradil; Myocardial Contraction; Perfusion; Radioligand Assay; Rats; Rats, Wistar; Ventricular Pressure | 2000 |
Pharmacological properties of Ca(V)3.2, a low voltage-activated Ca2+ channel cloned from human heart.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Cell Line; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Humans; Membrane Potentials; Mibefradil; Myocardium; Nickel; omega-Agatoxin IVA; omega-Conotoxins; Patch-Clamp Techniques; Perfusion; Tetrodotoxin; Transfection | 2000 |
Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967).
Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Cells, Cultured; Coronary Vessels; Diltiazem; Mibefradil; Muscle, Smooth, Vascular; Swine; Verapamil | 2000 |
Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Heart Failure; Hemodynamics; Hypertrophy, Left Ventricular; Male; Mibefradil; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ventricular Remodeling; Verapamil | 2001 |
L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amlodipine; Analgesics, Opioid; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Drug Synergism; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Male; Mibefradil; Mice; Morphine; Pain Measurement; Postural Balance; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord | 2001 |
Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Desoxycorticosterone; Hypertension, Renovascular; Kidney Diseases; Kidney Glomerulus; Male; Mibefradil; Proteinuria; Rats; Rats, Sprague-Dawley | 2001 |
Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Adhesion; Humans; Leukocytes; Mibefradil; Verapamil | 2002 |
Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil.
Topics: Adult; Amlodipine; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; CD18 Antigens; Cell Adhesion; Cells, Cultured; Cytoskeleton; Female; Flow Cytometry; Granulocytes; Humans; L-Selectin; Leukocytes; Male; Mibefradil; Microscopy, Confocal; Verapamil | 2002 |
Different effects of mibefradil and amlodipine on coronary vessels and during beta-adrenergic stimulation in conscious dogs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dogs; Drug Interactions; Electric Stimulation; Hemodynamics; Male; Mibefradil | 2002 |
Blood pressure response to antihypertensive agents related to baseline blood pressure.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Mibefradil; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2002 |
Effects of calcium channel blockers on "dynamic" and "steady-state step" renal autoregulation.
Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Feedback; Homeostasis; Kidney; Kidney Glomerulus; Magnetic Resonance Imaging; Male; Mibefradil; Organ Size; Rats; Rats, Sprague-Dawley; Renal Circulation | 2004 |
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
Topics: Albuminuria; Amlodipine; Animals; Azo Compounds; Blood Pressure; Calcium Channel Blockers; Collagen Type I; Coloring Agents; Diabetic Nephropathies; Fibronectins; Gene Expression; Kidney; Male; Mibefradil; Organ Size; Rats; Rats, Sprague-Dawley | 2004 |